Newsfiscal.ai
NeOnc Technologies to Present Clinical Data at Society for Neuro-Oncology Annual Meeting
· Published
Article summary
NeOnc Technologies Holdings, Inc. announced it will present updated clinical data for its intranasal NEO100 and oral NEO212 programs at the 31st Annual Meeting of the Society for Neuro-Oncology.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…